CRISPR-Cas9 Genome Editing for Precise Donor DNA Insertion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current genome editing tools, such as TALENs, face challenges in efficiently targeting specific DNA sequences due to repetitive sequences that complicate DNA construct synthesis and impair lentiviral gene delivery, while existing assays for evaluating NHEJ and HDR have limited sensitivity and accuracy, particularly in human induced pluripotent stem cells (hiPSCs).
Innovation Solution
The use of modified TALENs lacking repeat sequences longer than 100 bp, combined with guide RNAs and donor nucleic acids, enables precise DNA cleavage and insertion through nonhomologous end joining or homologous recombination, facilitated by RNA-guided DNA binding proteins like Cas9, allowing for multiplex genetic modifications in stem cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If TALENs with repeat sequences are used for genome editing, then DNA binding specificity is achieved, but DNA construct synthesis becomes complicated and lentiviral gene delivery is impaired
Solution Approach 1:
The patent extracts and removes the problematic repeat sequences from the TALEN DNA construct while preserving the essential DNA binding functionality through alternative design elements, thereby simplifying DNA construct synthesis and enabling lentiviral delivery without compromising target sequence specificity
Solution Approach 2:
The patent segments the TALEN construct into modular functional domains, separating the DNA binding specificity functions from the problematic repeat sequences, allowing independent optimization of each module for both specificity and manufacturability
2Ease of operation
If standard assays are used to evaluate NHEJ and HDR, then basic editing activity is detected, but sensitivity and accuracy are limited particularly in hiPSCs
Solution Approach 1:
The patent introduces intermediary molecular components and assay reagents that amplify the signal from editing events, enabling detection of low-frequency editing events in hiPSCs while maintaining operational simplicity through standardized protocol formats
Solution Approach 2:
The patent replaces traditional mechanical or manual assessment methods with molecular-based detection systems that provide automated, quantitative measurement of editing frequencies with enhanced sensitivity and accuracy
3Productivity
If high editing frequencies are achieved at some sites, then genome editing efficiency is improved, but editing is not detectable at other sites due to wide variation
Solution Approach 1:
The patent systematically varies key parameters including nuclease concentration, donor DNA ratio, cell cycle synchronization, and incubation conditions to identify optimal settings that achieve consistent high editing frequencies across diverse genomic sites
Solution Approach 2:
The patent employs dynamic optimization strategies where assay conditions and delivery parameters are adjusted based on specific target site characteristics, cell type, and experimental context to maximize editing efficiency at each location
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances genome editing efficiency in stem cells, achieving high frequencies of targeted DNA alterations and insertions, with improved sensitivity and accuracy in assays, and enables scarless genetic modifications using removable vectors.
Implementation Method 1
the cell undergoes nonhomologous end joining to produce altered DNA in the cell
Implementation Method 2
Bacterial and archaeal CRISPR-Cas systems rely on short guide RNAs in complex with Cas proteins to direct degradation of complementary sequences present within invading foreign nucleic acid
Implementation Method 3
introducing into a stem cell a first foreign nucleic acid encoding for an enzyme that forms a co-localization complex with RNA complementary to the target DNA and that cleaves the target DNA in a site specific manner
Implementation Method 4
the enzyme cleaves the target DNA and the donor nucleic acid is inserted into the target DNA to produce altered DNA in the stem cell
Data Source
AI summary
Methods are provided for altering target DNA in a cell genetically modified to express a Cas 9 enzyme that forms a co-localization complex with a guide RNA complementary to the target DNA and that cleaves the target DNA in a site specific manner. Methods include introducing into the cell a first foreign nucleic acid encoding a donor nucleic acid sequence, introducing into the cell from media surrounding the cell the guide RNA complementary to the target DNA and which guides the Cas 9 enzyme to the target DNA, wherein the RNA and the enzyme are members of a co-localization complex for the target DNA, wherein the donor nucleic acid sequence is expressed, wherein the guide RNA and the Cas 9 enzyme co-localize to the target DNA, the Cas 9 enzyme cleaves the target DNA and the donor nucleic acid is inserted into the target DNA to produce altered DNA in the cell.